I-Lifespans evamile iyafinyeleleka kodwa izinselelo Hlala
Kungokwemvelo ukuzibuza ukuthi ungaphila isikhathi eside kangakanani uma une-HIV. Ngenkathi abantu bezokuqinisekisa ukuthi yisifo esingelapheki, lokho kusho ukuthini ngokuphila nje kuphela kodwa izinga lomuntu lokuphila?
Impendulo ilula futhi ayiyona elula. Ngokubanzi, isimo sengqondo siphumelele kakhulu. Ngokuthuthukiswa kokwelashwa kwama-antiretroviral , abantu abanesandulela ngculaza bangalindela ukuphila isikhathi eside futhi bephilile kunanini ngaphambili Uma ukwelashwa kuqalwa kusenesikhathi futhi kuthathwa nsuku zonke njengoba kuqondiswe.
Eqinisweni, oneminyaka engu-20 ubudala oqale ukwelapha i-HIV angalindela ukuba aphile eminyakeni yawo-70 ubudala, ngokusho kocwaningo oluvela eNyakatho Melika ye-North American AIDS Cohort Cooperation on Research and Design (NA-ACCORD).
Ukubuyekezwa kocwaningo olwenziwa ngo-2011 kusukela eSwitzerland Cohort Study kuqhubekisele phambili ukusekela labo abatholayo, okuphakamisa ukuthi abantu abaqala ukwelashwa ekuqaleni (ekubalweni kwe-CD4 ngaphezu kuka-350) bangakwazi ukufezekisa isikhathi sokuphila esilingana noma esikhulu nakakhulu kunabantu abaningi.
Izinto Ezinciphisa Ukulindela Ukuphila
Kodwa lokho akusho ukuthi azikho izinselelo ezingabuyisa eziningi zalezi zindleko. Ngokombono womuntu ngamunye, ukuphila isikhathi eside kuncike ezinkingeni eziningi ezingase zandise noma zinciphise isikhathi sokuphila komuntu one-HIV. Lezi zici zivela ezintweni esingakwazi ukuzilawula (ezifana nokunamathela kwezidakamizwa ) ezintweni esingenakukwazi (ezifana nobuhlanga noma isimo sengeniso ).
Ngaphezu kwalokho, i-HIV empeleni iyingxenye yokukhathazeka kwesikhathi eside.
Ngisho nalabo abakwazi ukugcina umthamo wegciwane elingenakulinganiswa, ingozi yokuthi izifo ezingahlotshaniswa ne-HIV, ezifana nomdlavuza nesifo senhliziyo , zinkulu kakhulu kunabantu abaningi futhi zingenzeka noma kuphi kusukela eminyakeni engu-10 kuya ku-15 ngaphambili.
Okubaluleke kakhulu lokhu okukhathazayo ukuthi umuntu onesandulela ngculazi kungenzeka ukuthi angase afe ngaphambi kwesikhathi sokugula okungenayo igciwane lesandulelangculazi kunomuntu ohlobene ne-HIV.
Ukuzuza Nokulahlekelwa Eminyakeni Yokuphila
Izinto ezithinta isikhathi sokuphila ziba yi-static (fixed) noma zishintsha (zikwazi ukushintsha ngokuhamba kwesikhathi).
Izici ezizwakalayo , njengohlanga noma ubuhlobo bobulili, kuthinta isikhathi sokuphila ngoba yibo abantu ngokuvamile abakwazi ukuphunyuka. Isibonelo, amazinga aphezulu obuphofu emiphakathini yase-Afrika yaseMelika ehlangene nokuntuleka kokuthola usizo lwezempilo kanye namazinga aphezulu e-HIV ehlambalaza athatha izinzuzo eziningi ezitholakala emiphakathini emhlophe.
Izici ezinamandla , ngokuqhathanisa, zinezizathu ezibangela imbangela nezimpikiswano ngezikhathi zokusinda. Isibonelo, ukunamathela kwelashwa kuhlobene ngqo nokukhula kwesifo. Ukunamathela kancane kunakekelwa, ingozi enkulu yokumelana nezidakamizwa nokuhluleka kokwelashwa. Ngokwehluleka ngalunye, umuntu ulahlekelwa izinketho eziningi zokwelapha.
Uma sibheka kokubili izici ezinobungozi ezinamandla nezishukumisayo, singaqala ukukhomba lapho umuntu angathola khona noma alahlekelwe yimpilo-iminyaka engazi nakwazi. Phakathi kwazo:
- Inani le-CD4 yomuntu ekuqaleni kokuphathwa lihlala linye yezinkomba eziqine kakhulu zokuphila kwesikhathi. Ukuqala ukwelashwa uma isibalo se-CD4 singaphansi kuka-200 singagquma iminyaka engama-15 kusukela empilweni yomuntu .
- Ababhemayo abane-HIV balahlekelwa impilo eminingi-iminyaka yokubhema kune-HIV. Eqinisweni, ingozi yokufa ekubhemeni iphakeme kabili phakathi kwabokubhema abanegciwane lesandulela ngculaza futhi inganciphisa iminyaka engama-12 impilo yomuntu kungakhathaliseki ukuthi i-HIV.
- Ukuncintisana nokuphila isikhathi eside kuhlobene ngokuqondile ne-HIV. Ngokusho kocwaningo olusuka e-Bloomberg Public School of Health, abase-Afrika baseMelika base-HIV baphila iminyaka engama-8.5 ngaphansi kwamanye amhlophe.
- Abasebenzisi abasebenzisa izidakamizwa abajova balahlekelwa yizifo, kokubili ngokwegciwane lesandulela-ngculazi kanye nokungenalo i-HIV. Izimbangela eziqine kunazo zonke zazingezinkinga zokubambelela kanye nokutheleleka kwesifo sohlobo lwe-hepatitis C. Konke okushiwo, isikhathi sokuphila sokujova abasebenzisi bezidakamizwa singaphansi kweminyaka engama-20 kunamanye amaqembu e-HIV.
Izwi elivela
Ekugcineni, kubalulekile ukukhumbula ukuthi izibalo akuzona ukubikezela. Abakwazi ukubikezela ukuthi kuzokwenzekani ngesikhathi sokutheleleka.
Bangaphakamisa kuphela ukuthi yini ozoyithatha ukuze unciphise ingozi yokugula ngokusekelwe ezintweni wena, njengomuntu ngamunye, ongashintsha kalula.
> Imithombo:
> Hogg, R .; I-Althoff, K .; Samji, H. et al. "Ukwandisa esikhathini sokuphila phakathi kwabantu abathintekayo abane-HIV e-United States naseCanada, 2000-2007." I-7th International AIDS Society (IAS) Ingqungquthela yePathogenesis, Treatment and Prevention. I-Kuala Lumpur, e-Malaysia. Juni 30-Julayi 3, 2013; I-TUPE260 engabonakali.
> Hasse, B ,; Ledergerber, B .; Egger, M. et al. "Ukuguga futhi (okungekho-okuhlobene ne-HIV) Ukuhlukunyezwa kwabantu abane-HIV: Isifundo seSwitzerland Cohort (SHCS)." Ingqungquthela ye-18 yama-Retroviruses kanye nezifo ezithinta amathuba, iBoston; Februwari 27-Mashi 3, 2011; abstract 792.
> Thorsteinsson, K .; I-Ladelund, iS .; Jensen-Fangel, S. et al. "Impikiswano yobulili engozini yokugula izifo nokufa kwabantu ezigulini ezinegciwane lesandulela ngculaza le-HIV: 1 isifundo seqembu lonke." I-Scandinavia Journal of Infectious Disease. Okthoba 2012; 44 (10): 766-75. I-DOI: 10.3109 / 00365548.2012.684220,
> Helleberg, M .; Afzal, S; I-Kronborg, G. et al. "Ukufa okubangelwa ukubhema phakathi kwabantu abanegciwane lesandulela ngculazi-1: isifundo somphakathi esiphezulu esivela kuwo wonke amazwe." Izifo Ezithathelwanayo Emitholampilo. Mashi 2013; 56 (5): 727-34. I-DOI: 10.1093 / cid / cis933.
> Murray, M .; I-Hogg, R .; Lima, V .; et al. "Umthelela Wokusetshenziswa Kwezidakamizwa Umlando Wokugula Ukuthuthukiswa Nokufa Phakathi Kwabantu Abandulela I-HIV Abaqala Ukuhlanganiswa Ukwelashwa Kwe-Antiretroviral." I-HIV Medicine. Februwari 2012; 13 (2): 89-97. I-DOI: 10.1111 / j.1468-1293.2011.00940.x.